Physician
Illinois Center for Pain Control LLC
Illinois Center for Pain Control LLC was paid $2.62M by Medicaid between Jan 2018 and Nov 2024, across 36 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoILLINOIS CENTER FOR PAIN CONTROL LLC
MICHIGAN CITY, IN 46360
MICHIGAN CITY, IN 46360
33aNPI1437556941assigned 11/26/2014
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$2.62M
24GClaims64,798
24DCodes billed36
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Indiana
Rank by total paid#3 of 24
Median peer was paid$106K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,271 | $63K | |
| 2019 | 5,652 | $250K | |
| 2020 | 10,383 | $304K | |
| 2021 | 10,616 | $426K | |
| 2022 | 11,772 | $564K | |
| 2023 | 12,282 | $571K | |
| 2024incomplete | 7,822 | $441K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 18,917 | 16,555 | $1.02M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 23% | 15,817 | 13,799 | $601K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 20% | 9,212 | 7,795 | $517K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.7% | 1,071 | 900 | $98K |
| 72265 | 1.9% | 1,237 | 1,006 | $50K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.7% | 1,367 | 308 | $44K |
| 80348 | 1.1% | 1,200 | 1,064 | $29K | |
| 80354 | 1.1% | 1,198 | 1,062 | $29K | |
| 80365 | 1.1% | 1,198 | 1,061 | $29K | |
| 80373 | 1.1% | 1,198 | 1,062 | $29K | |
| 97535 | Self-care/home management training, each 15 minutes | 1.0% | 1,371 | 312 | $26K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 682 | 618 | $24K |
24 more codes
| 80372 | <1% | 768 | $17K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 465 | $15K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 482 | $14K |
| 80305 | <1% | 3,364 | $9K | |
| 81025 | <1% | 1,127 | $7K | |
| 77002 | <1% | 139 | $6K | |
| 80324 | <1% | 431 | $5K | |
| 80359 | <1% | 431 | $5K | |
| 80346 | <1% | 429 | $5K | |
| 80361 | <1% | 483 | $5K | |
| 80353 | <1% | 428 | $5K | |
| 80358 | <1% | 427 | $5K | |
| 64493 | <1% | 47 | $5K | |
| 99152 | <1% | 342 | $4K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 701 | $4K |
| 64494 | <1% | 47 | $3K | |
| 62323 | <1% | 12 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 70 | $1K |
| 97162 | <1% | 19 | $810.38 | |
| 80355 | <1% | 37 | $684.00 | |
| 99307 | <1% | 13 | $128.92 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 13 | $68.16 |
| 99490 | Ccm add 20min | 0% | 43 | $0.00 |
| 98926 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQUADRI, SYED (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Central Medical Associates PLLC | Elizabethtown, KY | $4.90M |
| Axess Clinic and Diagnostics LLC | Michigan City, IN | $1.88M |
| Psych Pointe of Florida PLC | Orlando, FL | $303K |
| Quadri Psychiatry PLLC | Las Vegas, NV | $174K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.